Natalie Giovino

Natalie Giovino is a senior clinical trial leader at Kura Oncology, Inc., with extensive experience in leading complex phase I/II oncology biomarker-driven clinical trials, including combination and First In Human (FIH) studies, as well as managing vendors throughout the trial process. Prior to Kura Oncology, Natalie served as a graduate scientist at AstraZeneca, where involvement in various R&D placements fostered strong communication skills with clinical researchers. Experience as a data assistant at Penn Medicine and multiple research internships at prestigious institutions, including Columbia University Medical Center and Memorial Sloan Kettering Cancer Center, contributed to a robust background in oncology research. Natalie holds a Master's degree in Bioengineering and Biomedical Engineering from the University of Pennsylvania and a Bachelor's degree in Chemistry from Haverford College, complemented by international study at Lund University.